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Abstract
Background: Transfusion-transmissible infectious agents such as human immunodeficiency virus (HIV), hepatitis B
virus (HBV), hepatitis C virus (HCV) and syphilis are among the greatest threats to blood safety for the recipient.
This study aimed to determine the seroprevalence, risk factors and trends of HIV, HBV, HCV and syphilis infections
among blood donors over a period of five years at Gondar University Teaching Hospital, Northwest Ethiopia.
Methods: A retrospective analysis of consecutive blood donors’ records covering the period between January 2003
and December 2007 was conducted. Logistic regression analysis was used to determine risk factors associated with
HIV, HBV, HCV and syphilis infections.
Results: From the total of 6361 consecutive blood donors, 607 (9.5%) had serological evidence of infection with at
least one pathogen and 50 (0.8%) had multiple infections. The overall seroprevalence of HIV, HBV, HCV and syphilis
was 3.8%, 4.7%, 0.7%, and 1.3% respectively. Among those with multiple infections, the most common
combinations were HIV - syphilis 19 (38%) and HIV - HBV 17 (34%). The seropositivity of HIV was significantly
increased among female blood donors, first time donors, housewives, merchants, soldiers, drivers and construction
workers. Significantly increased HBV seropositivity was observed among farmers, first time donors and age groups
of 26 - 35 and 36 - 45 years. Similarly, the seroprevalence of syphilis was significantly increased among daily
labourers and construction workers. Statistically significant association was observed between syphilis and HIV
infections, and HCV and HIV infections. Moreover, significantly declining trends of HIV, HCV and syphilis
seropositivity were observed over the study period.
Conclusions: A substantial percentage of the blood donors harbour HIV, HBV, HCV and syphilis infections. Strict
selection of blood donors and comprehensive screening of donors’ blood using standard methods are highly
recommended to ensure the safety of blood for recipient.
Background
The discovery of transfusion-transmissible infections
(TTIs) has heralded a new era in blood transfusion prac-
tice worldwide with emphasis on two fundamental
objectives, safety and protection of human life [1]. Blood
safety remains an issue of major concern in transfusion
medicine in Ethiopia where national blood transfusion
services and policies, appropriate infrastructure, trained
personnel and financial resources are inadequate.
Human immunodeficiency virus (HIV), hepatitis B virus
(HBV) and hepatitis C virus (HCV) are of great concern
because of their prolonged viraemia and carrier or latent
state. They also cause fatal, chronic and life-threatening
disorders. Blood transfusion accounts for 5-10% of HIV
infections in sub-Saharan Africa [2]. Similarly, 12.5% of
patients who received blood transfusion are at risk of post-
transfusion hepatitis [3]. HBV is highly contagious and
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relatively easy to be transmitted from one infected indivi-
dual to another by blood transfusion, during birth, by
unprotected sex, and by sharing needles and has a rela-
tively higher prevalence in the tropics [4,5]. A study con-
ducted in Addis Ababa, Ethiopia showed that HCV
antibody prevalence was 0.9% and higher among HIV-
positive compared to HIV-negative individuals (4.5% vs.
0.8%, respectively). Similarly, higher prevalence of HCV
antibodies was seen among HIV-positive compared to HIV
negative antenatal care attenders (2.9% vs. 0.8%, respec-
tively), and sex workers (5.3% vs. 1.3%, respectively) [6].
Syphilis is also a systemic disease caused by Trepo-
nema pallidum which can be spread by sexual contact,
blood transfusion and via vertical transmission [7]. In
sub-Saharan Africa, syphilis remains a serious public
health problem. Prevalence of active syphilis infection
among African countries showed 12.8% in Tanzania [8],
and 3.8% in Kenya [9]. A study conducted to assess the
prevalence of infection with HIV, syphilis and HBV
among Ethiopian blood donors in 1995 showed that the
seroprevalence of HIV-1, syphilis and HBV was 16.7%,
12.8% and 14.4%, respectively [10].
The high prevalence of HIV, HBV, HCV and syphilis
has heightened the problems of blood safety in Ethiopia.
Thus, continuous monitoring of the magnitude of trans-
fusion-transmissible infections in blood donors is impor-
tant for estimating the risk of transfusion and
optimizing donor recruitment strategies to minimize
infectious diseases transmission. Therefore, this study
was conducted to determine the seroprevalence, risk fac-
tors and trends of HIV, HBV, HCV and syphilis infec-
tions among blood donors at Gondar University
Teaching Hospital in Northwest Ethiopia.
Methods
Study design, setting and study subjects
A retrospective analysis of consecutive blood donors’
records covering the period between January 2003 and
December 2007 was conducted at Gondar University
Teaching Hospital. The hospital is a tertiary level teach-
ing hospital that provides health service to over five mil-
lion inhabitants in Northwest Ethiopia, and is located
727 Km north from the capital city, Addis Ababa. Insti-
tutional ethical clearance was obtained from the
research and publication committee of Gondar Univer-
sity. However, due to the nature of the study (retrospec-
tive review of blood donors’ records), informed consent
was not obtained from the study subjects.
Blood donors were either volunteers, or relatives or
friends of patients and commercial donors who were
recruited and paid by patients, their families, or friends
to replace blood used or expected to be used for patients
from the blood bank of the hospital. In the blood bank
unit of the hospital, the first step in screening for
potential blood donors is taking past medical history of
the client. Individuals are required to give answers to a
panel of questions on previous illnesses and medical con-
ditions. Past history of blood transfusion and questions
targeted to ascertain risky sexual behavior and practice
are also part of the questionnaire. Apparently healthy
subjects of age 17 to 65 years with body weight above 45
kg would qualify for donation. The medical and socio-
demographic histories of the donors were recorded in the
logbook and venous blood was collected in blood bank-
ing bags following standard procedures.
Laboratory diagnosis for HIV 1 and 2
Each donor’s serum sample was screened for HIV-1 and
HIV-2 using Vironostika HIV Uni-Form II Ag/Ab (Bio-
Merieux, Boxtel, The Netherlands) following the manu-
facturer’s instructions.
Laboratory tests for HBsAg and HCV antibodies
Sera were checked for the presence of hepatitis B sur-
face antigen (HBsAg) using ELISA, Hepanostika HBsAg
(Murex Biotech Ltd, Dartford, UK). Similarly, IgG anti-
bodies to HCV were detected using an ELISA technique
(Murex anti-HCV version 4.0) according to the manu-
facturer’s instructions.
Laboratory diagnosis for syphilis
Serum from all donors was tested for the presence of
treponemal antibodies using rapid plasma reagin test
(RPR) following the manufacturer’s instructions (RPR,
Wampole Laboratories, Princeton, N.J., USA).
ABO blood grouping and Rhesus (RH) typing
ABO and Rh blood groups determinations were carried
out on a slide using monoclonal blood grouping anti-
sera; anti-A, anti-B, anti-AB, and anti-D (BIOTEC
Laboratories Ltd, Great Britain).
Statistical analysis
Data were entered, cleaned and analysed using SPSS ver-
sion 13 statistical package. To ensure the quality of data
entered into the computer, two people independently
cross-checked each entry. Differences in prevalence of
HIV, HBV, HCV and syphilis for Socio-demographic
variables were tested for significance using logistic
regression. Moreover, linear regression was used to assess
the statistical significance of trends in seroprevalence of
these pathogens over the study period. P value less than
0.05 was considered statistically significant.
Results
Demographic characteristics of donors
As shown in Table 1, a total of 6361 consecutive blood
donors were screened at Gondar University Teaching
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Hospital blood bank unit during the study period. Of
these, 5592 (87.9%) donors were males and 769
(12.1%) were females. The median age of the study
subjects was 25 years (range 17 - 65 years). Of all
donors, 3357 (52.8%) were in the age group of 17-25
years, 4372 (68.7%) were first time donors, 2952
(46.4%) were blood group O and 5984 (94.1%) were
Rhesus D (RH) positive. In addition, daily labourers
(27.8%), farmers (24.8%) and students, more frequently
Collage/University students (21.2%) were constitute a
major chunk of the blood donors. The relatively higher
number of farmer and daily labourer donors may be
due to the fact that farmers constitute a major portion
of the general population and majority of the commer-
cial blood donors are daily labourers.
Seroprevalence of HIV, HBV, HCV and syphilis
The overall seroprevalence rate of HIV, HBV, HCV and
syphilis was 3.8%, 4.7%, 0.7% and 1.3% respectively
(Table 2). Of all donated blood during the study period,
607 (9.5%) had serological evidence of infection with at
least one pathogen and 50 (0.8%) had multiple infec-
tions. Among those with multiple infections, the most
common combinations were HIV- syphilis 19 (38%) and
HIV - HBV 17 (34%) (Table 3). As shown in Table 4,
the seroprevalence of HIV was significantly increased
among female blood donors (P < 0.001) compared to
male blood donors, first time donors (P < 0.001) com-
pared to repeat donors, and among housewives (P <
0.001), merchants (P < 0.001), soldiers (P = 0.020), dri-
vers (P = 0.041) and construction workers (P = 0.009)
compared to students. The seroprevalence of syphilis
was significantly increased among daily labourers (P =
0.001) and construction workers (P = 0.013) compared
to students. Similarly, the seropositivity of HBV was sig-
nificantly increased among donors with the age groups
of 26 - 35 and 36 - 45 years compared to the age group
Table 1 Socio—demographic characteristics of blood
donors at Gondar University Teaching Hospital in
Northwest Ethiopia 2003-2007
Characteristics Number (%)
Age group (years)
17 – 25 3357 (52.8)
26 – 35 1686 (26.5)
36 – 45 757 (11.9)
46 – 55 395 (6.2)
56 – 65 166 (2.6)
Gender
Male 5592 (87.9)
Female 769 (12.1)
Occupation
Daily labourer 1769 (27.8)
Farmer 1575 (24.8)
Student 1347 (21.2)
Housewife 212 (3.3)
Govt. employee 599 (9.4)
Merchant 333 (5.2)
Soldier 47 (0.7)
Driver 120 (1.9)
Construction worker 343 (5.4)
Others 16 (0.3)
Number of donation
First donation 4372 (68.7)
Repeat donation 1989 (31.3)
ABO Blood groups
O 2952 (46.4)
A 1715 (27.0)
B 1406 (22.1)
AB 288 (4.5)
Rhesus (RH) type
Positive 5984 (94.1)
Negative 377 (5.9)
Table 2 Trends of seropositivity of HIV, Syphilis, HBV and HCV among blood donors at Gondar University Teaching
Hospital in Northwest Ethiopia 2003 - 2007
Year Total screened
N
HIV positive
N (%)
Syphilis positive
N (%)
HBV positive
N (%)
HCV positive
N (%)
2003 1156 58 (5.0) 45 (3.9) 62 (5.4) X
2004 1693 61 (3.6) 33 (1.9) 85 (5.0) 23 (1.4)
2005 1187 47 (4.0) 1 (0.1) 63 (5.3) 7 (0.6)
2006 1045 33 (3.2) 2 (0.2) 30 (2.9) 3 (0.3)
2007 1280 40 (3.1) 2 (0.2) 58 (4.5) 2 (0.2)
Total 6361 239 (3.8) 83 (1.3) 298 (4.7) 35 (0.7)
p-Value of linear regression for trend _ 0.021 <0.001 0.061 <0.001
N = Number; X = Not done
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greater than 45 years, farmers (P = 0.005) compared to
students and first time donors (P < 0.001) compared to
repeat donors (Table 5).
The prevalence rate of syphilis, HBV and HCV among
HIV infected donors was 7.9%, 7.1%, and 2.2% respec-
tively, compared with the prevalence rate of 1.0%, 4.6%
and 0.6% among HIV-seronegative donors. Furthermore,
statistically significant association was observed between
syphilis and HIV infection (P < 0.001) (Table 4), and
HCV and HIV infection (P = 0.002) (Table 5).
Trends of HIV, HBV, HCV and syphilis seroprevalence
Significantly declining trends of HIV (P = 0.021), HCV
(P < 0.001) and syphilis (P < 0.001) seroprevalence were
observed over the five years study period. The seropre-
valence of HIV was 5.0% in 2003 and decreased to 3.6%
in 2004 and slightly increased to 4.0% in 2005 but sub-
sequently decreased to 3.2% in 2006 and 3.1% in 2007.
The seroprevalence of HBV was decreased from 5.4% in
2003 to 2.9% in 2006 and increased further to 4.5%
in 2007. HCV prevalence decreased steadily from 1.4%
in 2004 to 0.6% in 2005, 0.3% in 2006, and 0.2% in
2007. Similarly, the prevalence of syphilis decreased pro-
gressively from 3.9% in 2003 to 1.9% in 2004, 0.1% in
2005 and 0.2% in 2006 and 2007 (Table 2).
Discussion
In this study, significantly declining trends of HIV, HCV
and syphilis seroprevalence were observed among blood
donors over the study period. This finding is consistent
with the observed declining trend of HIV seroprevalence
in the general population in Ethiopia [11], declining
trend of HIV prevalence among blood donors in Ethio-
pia [12], declining trend of HIV prevalence among
Table 3 Prevalence of co-infections of HIV, HBV, HCV and
syphilis among blood donors at Gondar University
Teaching Hospital in Northwest Ethiopia 2003-2007
Co-infections Number Percent
HIV - Syphilis 19 38.0
HIV - HBV 17 34.0
HIV - HCV 4 8.0
HBV - Syphilis 7 14.0
HBV - HCV 2 4.0
Syphilis - HCV 1 2.0
Total 50 100
Table 4 Socio–demographic characteristics of blood donors by HIV and Syphilis sero positivity at Gondar University
Teaching Hospital in Northwest Ethiopia 2003-2007
Characteristics HIV Positive
N (%)
OR (95% CI) P-Values Syphilis Positive
N (%)
OR (95% CI) P-Values
Age group (years)
17 – 25 105/3357 (3.1) 1.03 (0.61 - 1.74) 0.902 31/3357 (0.9) 0.64 (0.30 - 1.41) 0.271
26 – 35 79/1686 (4.7) 1.57 (0.92 - 2.68) 0.096 28/1686 (1.7) 1.17 (0.53 - 2.58) 0.702
36 – 45 38/757 (5.0) 1.69 (0.94 - 3.03) 0.077 16/757 (2.1) 1.49 (0.63 - 3.51) 0.359
> 45 17/561 (3.0) 1.00 - 8/561 (1.4) 1.00 -
Gender
Male 188/5592 (3.4) 1.00 - 76/5592 (1.4) 1.00 -
Female 51/769 (6.6) 2.04 (1.48 - 2.81) <0.001 7/769 (0.9) 0.67 (0.31 - 1.45) 0.307
Occupation
Student 34/1347 (2.5) 1.00 _ 9/1347 (0.7) 1.00 _
Daily labourer 53/1769 (3.0) 1.19 (0.77 - 1.85) 0.429 38/1769 (2.1) 3.26 (1.57 - 6.77) 0.001
Farmer 56/1575 (3.6) 1.42 (0.92 - 2.19) 0.109 20/1575 (1.3) 1.91 (0.87- 4.21) 0.108
Housewife 26/212 (12.3) 5.40 (3.17 - 9.20) <0.001 3/212 (1.4) 2.13 (0.57 - 7.95) 0.258
Govt.employee 17/599 (2.8) 1.13 (0.63 - 2.04) 0.689 0/599 - -
Merchant 23/333 (6.9) 2.87 (1.66 - 4.93) <0.001 4/333 (1.2) 1.81 (0.55-5.91) 0.327
Military 4/47 (8.5) 3.59 (1.22 -10.57) 0.020 0/47 - -
Driver 7/120 (5.8) 2.39 (1.04 - 5.52) 0.041 1/120 (0.8) 1.25 (0.16 - 9.95) 0.833
Construction worker 19/359 (5.3) 2.16 (1.22 - 3.83) 0.009 8/359 (2.2) 3.39 (1.30 - 8.85) 0.013
Number of donation
First donation 212/4372 (4.8) 3.70 (2.47 - 5.55) <0.001 56/4372 (1.3) 0.94 (0.59 - 1.50) 0.803
Repeat donation 27/1989 (1.4) 1.00 - 27/1989 (1.4) 1.00 -
HIV status
Positive - - - 19/239 (7.9) 8.18 (4.81- 13.88) <0.001
Negative - - - 64/6122 (1.0) 1.00 -
OR = Odds ratio; CI = Confidence interval; N = Negative
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pregnant women, and declining trend of syphilis infec-
tions among pregnant women in Addis Ababa [13]. The
initial rise in HIV seroprevalence among the blood
donors represents the peak of the epidemic when denial
was prevalent and little attention was paid to the dis-
ease. The subsequent decline in HIV seroprevalence
may be due to the effect of the prevention programs
that have been instituted in recent years [14].
The overall seroprevalence of HIV (3.8%) in this
study is similar to the 3.8% seroprevalence in Ghana
[15]. However, it is lower when compared with the
5.5% in Maiduguri [16], 10.6% in Nigeria [17] and
16.7% in Ethiopia [10]. The significantly increased
HIV seropositivity among female donors compared to
male donors is in accordance with the previous report
[18]. This significantly increased HIV seropositivity
among female donors might be due to their increased
vulnerability to HIV infection as a result of biological,
social and economic disadvantages related to their
gender [19].
In the present study, the seropositivity rate of HIV and
HBV was significantly increased among first time donors
compared to repeat donors. This is in agreement with the
previous studies [20-22]. The significantly increased HIV
and HBV seroprevalence among first time donors might
be due to the fact that people who regularly donate blood
usually have a profile of low-risk of HIV and HBV infec-
tion because they were selected many times [23]. The sig-
nificantly increased HIV seroprevalence among housewife
donors is also consistent with previous study [24] which
shows that these women acquired the infection from their
partners, who commonly have sexual relations with other
women without their partner’s knowledge. The partner,
considering her relationship to be monogamous, does not
use protective methods to avoid infection.
The seroprevalence of HBV (4.7%) is lower than the
previous reports, 10.4% in Nigeria [25], 15.0% in Ghana
[15] and 14.4% in Ethiopia [10]. The seroprevalence rate
of HCV (0.7%) is in agreement with values ranging
between 0 and 1.4% reported from USA and Europe
[26,27] and 0.9% in Ethiopia [6]. However, it is lower
than the 2.8% in Ghana [28] and the 2.9% in Port Har-
court [29]. Similarly, the seroprevalence of syphilis
(1.3%) in this study is lower than the 3.6% in Maiduguri
[23], 7.5% in Ghana [30], 12.8% in Ethiopia [31] and
12.7% in Tanzania [32] but is higher than the 0.1%
Table 5 Socio–demographic characteristics of blood donors by hepatitis B and C virus seropositivity at Gondar
University Teaching Hospital in Northwest Ethiopia 2003-2007
Characteristics HBV Positive
N (%)
OR (95% CI) P-Values HCV Positive N (%) OR (95% CI) P-Values
Age group (years)
17 - 25 144/3357 (4.3) 1.43 (0.86 - 2.39) 0.166 16/2726 (0.6) 0.91 (0.26 - 3.12) 0.875
26 - 35 89/1686 (5.3) 1.78 (1.05 - 3.02) 0.032 13/1395 (0.9) 1.44 (0.41 - 5.08) 0.569
36 - 45 48/757 (6.3) 2.17 (1.23 - 3.81 0.007 3/621 (0.5) 0.74 (0.15 - 3.71) 0.718
> 45 17/561 (3.0) 1.00 - 3/463 (0.6) 1.00 -
Gender
Male 273/5592 (4.9) 1.00 - 34/4528 (0.8) 1.00 -
Female 25/769 (3.3) 0.66 (0.43 - 0.99) 0.046 1/677 (0.1) 0.20 (0.03 - 1.43) 0.108
Occupation
Student 55/1347 (4.1) 1.00 _ 6/1188 (0.5) 1.00 _
Daily labourer 79/1769 (4.5) 1.10 (0.77 - 1.56) 0.602 8/1312 (0.6) 1.21 (0.42 - 3.49) 0.726
Farmer 102/1575 (6.5) 1.63 (1.16 - 2.28) 0.005 14/1293 (1.1) 2.16 (0.83 - 5.63) 0.117
Housewife 7/212 (3.3) 0.80 (0.36 - 1.79) 0.589 1/179 (0.6) 1.11 (0.13 - 9.25) 0.925
Govt.employee 20/599 (3.3) 0.81 (0.48 - 1.37) 0.432 2/525 (0.4) 0.75 (0.15 - 3.75) 0.729
Merchant 12/333 (3.6) 0.88 (0.47 - 1.66) 0.689 0/288 - -
Military 2/47 (4.3) 1.04 (0.25 - 4.42) 0.953 0/34 - -
Driver 4/120 (3.3) 0.81 (0.29 - 2.28) 0.689 0/103 - -
Construction worker 17/359 (4.7) 1.17 (0.67 - 2.04) 0.585 4/283 (1.4) 2.82 (0.79 - 10.08) 0.110
Number of donation
First donation 231/4372 (5.3) 1.60 (1.21 - 2.11) <0.001 25/3610 (0.7) 1.11 (0.53 - 2.31) 0.79
Repeat donation 67/1989 (3.4) 1.00 - 10/1595 (0.6) 1.00 -
HIV status
Positive 17/239 (7.1) 1.59 (0.96 - 2.64) 0.07 4/181 (2.2) 3.64 (1.27- 10.42) 0.02
Negative 281/6122 (4.6) 1.00 - 31/5024 (0.6) 1.00 -
OR = Odds ratio; CI = Confidence interval; N = Negative
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reported in Port Harcourt [33]. The reason(s) for the
relatively lower rate of seroprevalence of HBV, HCV
and syphilis in this study compared with other studies
cannot be discerned. The improvement in technology
might make current screening reagents to be more spe-
cific and reliable; and could also be a pointer that there
are geographical differences in prevalence.
Significantly increased in seroprevalence of HBV was
observed in the age groups of 26 - 35 and 36 - 45 years
compared to the age group of greater than 45 years.
This is in concurrence with previous reports by Baba
et al. [16] and Ejele et al. [33] in which higher preva-
lence was observed among youths. This observation is
worrisome since the most productive and economically
viable age group of the populations is worst hit. There
is the need for renewed intensification of preventive
programmes aimed at high risk behavioural change.
In this study, high prevalence rate of HIV, HBV, HCV
and syphilis co-infections was revealed among blood
donors. However, none of the donors showed the
presence of three or four markers. The HIV - HBV
co-infection rate of 17/50 (34%) and the 19/50 (38%)
HIV - syphilis co-infection observed in this study are
higher than the result in Port Harcourt[33] and lower
than the 40% HIV/HBV co-infection rate reported by
Lodenyo et al. [34]. This high rate of co-infection and
the statistically significant relationship between HIV and
syphilis, and HIV and HCV infections might be due to
the fact that these pathogens share common modes of
transmission and risk groups [6,16,25,35].
Conclusion
A substantial percentage of the blood donors harbour
transfusion-transmissible infections, 9.5% with at least
one pathogen and 0.8% with multiple infections. Trans-
mission of transfusion-transmissible infections during
the serologically negative window period still pose a
threat to blood safety in environments where there is a
high rate of transfusion-transmissible infection. There-
fore, strict selection of blood donors with the emphasis
on getting voluntary donors and comprehensive screen-
ing of donors’ blood for HIV, HBV, HCV and syphilis
using standard methods are highly recommended to
ensure the safety of blood for recipient. The prevalence
of HIV, HBV, HCV, and syphilis co-infection needs to
be studied on a larger scale for the better understanding
of the impact on clinical outcome and treatment
response.
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